Does TAFASITAMAB Cause Weight decreased? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Weight decreased have been filed in association with TAFASITAMAB (MONJUVI). This represents 1.2% of all adverse event reports for TAFASITAMAB.
16
Reports of Weight decreased with TAFASITAMAB
1.2%
of all TAFASITAMAB reports
4
Deaths
9
Hospitalizations
How Dangerous Is Weight decreased From TAFASITAMAB?
Of the 16 reports, 4 (25.0%) resulted in death, 9 (56.3%) required hospitalization.
Is Weight decreased Listed in the Official Label?
Yes, Weight decreased is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Weight decreased?
ADALIMUMAB (9,387)
INFLIXIMAB (5,612)
METHOTREXATE (5,432)
SACUBITRIL\VALSARTAN (5,030)
RITUXIMAB (4,866)
APREMILAST (4,692)
PREDNISONE (4,351)
LENALIDOMIDE (4,235)
ETANERCEPT (3,609)
SEMAGLUTIDE (3,518)
Which TAFASITAMAB Alternatives Have Lower Weight decreased Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR